According to TipRanks.com, McGinley is ranked #2176 out of 5717 analysts.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Curaleaf Holdings with a $11.59 average price target, representing a 94.4% upside. In a report issued on November 20, Cowen & Co. also maintained a Buy rating on the stock with a $9.50 price target.
The company has a one-year high of $11.73 and a one-year low of $3.88. Currently, Curaleaf Holdings has an average volume of 522.5K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Curaleaf Holdings, Inc. is a life science company, which engages in owning and managing licensed cannabis businesses which cultivate, process and/or dispense cannabis and cannabis derived products. It operates through Cannabis Operations and Non-Cannabis Operations segments.